|
"bardia aditya"的相关文件
显示项目 1-3 / 3 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-03-22T15:05:34Z |
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
|
YEN-SHEN LU; Im, Seock Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Cardoso, Fatima; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; O'Regan, Ruth; Gasch, Claudia; Solovieff, Nadia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Ji, Yan; Tripathy, Debu |
| 臺大學術典藏 |
2021-11-21T23:19:52Z |
Genomic profiling of premenopausal HR+ and HER2– metastatic breast cancer by circulating tumor DNA and association of genetic alterations with therapeutic response to endocrine therapy and ribociclib
|
Bardia, Aditya; Su, Fei; Solovieff, Nadia; Im, Seock Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Colleoni, Marco; Vázquez, Rafael Villanueva; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Taran, Tetiana; Lorenc, Karen Rodriguez; Babbar, Naveen; Tripathy, Debu; YEN-SHEN LU |
| 國立臺灣大學 |
2015 |
A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
|
Parton, Marina; Bardia, Aditya; Kummel, Sherko; Estevez, Laura G.; Huang, Chiun-Sheng; Castan, Javier Cortes; Borrego, Manuel Ruiz; Telli, Melinda L.; Lluch, Ana; Lopez, Rafael; Beck, J. Thaddeus; Ismail-Khan, Roohi; Chen, Shin-Cheh; Hurvitz, Sara A.; Mayer, Ingrid A.; Atienza, Rolando S.; Cameron, Scott; Krygowski, Mizue; Kim, Sung-Bae; 黃俊升 |
显示项目 1-3 / 3 (共1页)
1
每页显示[10|25|50]项目
|
